| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/31/2012 | US8106045 2-morpholino-4-pyrimidone compound |
| 01/31/2012 | US8106044 8-{4-[3-(5-fluoro-1H-indol-3-yl)-propyl]-piperazin-1-yl}-2-methyl-4H-benzo[1,4]oxazin-3-one mesylate with high affinity for the dopamine D2 receptor and the serotonin reuptake site |
| 01/31/2012 | US8106043 Benzoxazines, benzothiazines, and related compounds having NOS inhibitory activity |
| 01/31/2012 | US8106042 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives useful as modulator of nicotinic acetylcholine receptors |
| 01/31/2012 | US8106041 Combination product comprising an antagonist or inverse agonist of histamine receptor H3 and an antipsychotic and antidepressant agent, and use thereof for the preparation of a medicament that prevents the adverse effects of psychotropic drugs |
| 01/31/2012 | US8106040 penicillin, a cephalosporin, a carbapenem antibiotics in a liquid containing triglyceride; clavulanic acid as lactamase/beta-/ inhibitor; active against both gram-positive and gram-negative bacteria; |
| 01/31/2012 | US8106039 Metal complex phosphatidyl-inositol-3-kinase inhibitors |
| 01/31/2012 | US8106038 Method for reducing or preventing PDT related inflammation |
| 01/31/2012 | US8106037 Identification and treatment of estrogen responsive prostate tumors |
| 01/31/2012 | US8106036 Pharmaceutical compositions-4 |
| 01/31/2012 | US8106035 For therapy and prophylaxis of cancer, dermatological disorders, bone disorders, thyroid disorders, wound healing and osteoporosis |
| 01/31/2012 | US8106034 Angiotensin II receptor antagonists |
| 01/31/2012 | US8106033 (E)-2-(5-((2,4,6-trimethoxystyrylsulfonyl)methyl)-2-methoxyphenylamino)acetic acid; antiproliferative; anticarcinogenic agent : solid tumors, leukemia; "cytoproliferative" diseases: atherosclerosis, fibrosis, Paget's disease; synergistic effect with other active ingredients |
| 01/31/2012 | US8106032 Lipid analogs for combating tumors |
| 01/31/2012 | US8106031 Hydrolytically-resistant boron-containing therapeutics and methods of use |
| 01/31/2012 | US8106029 Use of A2A adenosine receptor agonists |
| 01/31/2012 | US8106027 Development of a preventive vaccine for filovirus infection in primates |
| 01/31/2012 | US8106026 Development of a preventive vaccine for filovirus infection in primates |
| 01/31/2012 | US8106023 1,4-benzothiepin-1, 1-dioxide derivatives with improved properties method for producing the same, drugs containing said compounds and the use thereof |
| 01/31/2012 | US8106022 Carbohydrate conjugates as delivery agents for oligonucleotides |
| 01/31/2012 | US8106021 Benzylbenzene derivatives and methods of use |
| 01/31/2012 | US8106016 Compounds and compositions for prevention of overdose of oxycodone |
| 01/31/2012 | US8106007 Having affinity to antithrombin III; improved pharmacokinetic properties when compared to the original polypeptides |
| 01/31/2012 | US8105993 Process compositions and production of acyl alkylisethionate compositions |
| 01/31/2012 | US8105830 Polyspecific binding molecules and uses thereof |
| 01/31/2012 | US8105798 Identifying modulators which control migration of nuclear receptor from nucleus to non-nuclear cell target; screening for agent which prevent and treat cell proliferative disorders |
| 01/31/2012 | US8105636 Compositions and methods for treating inflammation and inflammation-related disorders by Plectranthus amboinicus extracts |
| 01/31/2012 | US8105635 Post-impregnation treatments to improve distribution of metal biocides in an impregnated substrate |
| 01/31/2012 | US8105631 Opioid agonist/antagonist combinations |
| 01/31/2012 | US8105630 Composition containing medicine extremely slightly soluble in water being excellent in eluting property and method for preparation thereof |
| 01/31/2012 | US8105628 Mixture of biocompatible putty containing bulking agent, metal compound and polymer |
| 01/31/2012 | US8105627 Extended release venlafaxine tablet formulation |
| 01/31/2012 | US8105626 Granules containing acid-unstable chemical in large amount |
| 01/31/2012 | US8105618 Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide |
| 01/31/2012 | US8105609 Administering a vaccine of a nucleic acid having a transcriiptional unit (TU) to direct a host cell to to biosynthesize the matrix and envelope (M and E) protein antigens; the TU comprises a prM signal sequence and ribosomal bindng sequence; carriers; encephalitis and yellow fever |
| 01/31/2012 | US8105608 Method of treatment using ligand-immunogen conjugates |
| 01/31/2012 | US8105605 Allergen formulation |
| 01/31/2012 | US8105599 Administering a compound which binds to a C-type lectin on the surface of a dendritic cell, with the proviso that the C-type lectin is not the DEC-205 receptor |
| 01/31/2012 | US8105596 Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
| 01/31/2012 | US8105583 Solubilized CoQ-10 |
| 01/31/2012 | US8105580 Methods of using adipose derived stem cells to promote wound healing |
| 01/31/2012 | US8105579 Bacteriophage-containing therapeutic agents |
| 01/31/2012 | US8105570 Methods and compositions for controlled release of drugs |
| 01/31/2012 | CA2670292C Novel hydrophilic derivatives of 2-aryl-4-quinolones as anticancer agents |
| 01/31/2012 | CA2669849C Crystalline forms of (3s)-3-[n-(n'-(2-tert-butylphenyl)oxamyl)alaninyl]amino-5-(2',3',5',6'-tetrafluorophenoxy)-4-oxopentanoic acid |
| 01/31/2012 | CA2663398C A cancer sensitizer comprising glucosamine, glucosamine derivatives or salts thereof |
| 01/31/2012 | CA2659222C Formulations of radioprotective .alpha., .beta. unsaturated aryl sulfones |
| 01/31/2012 | CA2575237C Processes for producing cellooligosaccharide |
| 01/31/2012 | CA2564043C Hair restorer |
| 01/31/2012 | CA2558233C Composition for medical use having improved water-solubility of peptide and metal-labeling efficiency and preparation for medical use comprising metal-labeled peptide |
| 01/31/2012 | CA2553646C Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage |
| 01/31/2012 | CA2550373C Anti-hypercholesterolemic compounds |
| 01/31/2012 | CA2546476C Pharmaceutical preparation containing gabapentin |
| 01/31/2012 | CA2536828C Food product providing sustained blood levels of exogenous substances |
| 01/31/2012 | CA2529649C Substituted spirobenzazepines |
| 01/31/2012 | CA2516698C Novel transcriptional factor, process for producing the same and use thereof |
| 01/31/2012 | CA2509449C Lyophilized preparation of stabilized anthracycline compounds |
| 01/31/2012 | CA2509157C Process for preparing optically active dihydropyrones |
| 01/31/2012 | CA2508022C Mastitis treatment |
| 01/31/2012 | CA2504718C Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 01/31/2012 | CA2496897C Methods and compositions for modulating xbp-1 activity |
| 01/31/2012 | CA2493023C Use of alkylphosphocholines in combination with antitumor medicaments |
| 01/31/2012 | CA2463989C Pyrimidine derivatives, pharmaceutical compositions containing these compounds, the use thereof and process for the preparation thereof |
| 01/31/2012 | CA2447990C Encapsulation of nanosuspensions in liposomes and microspheres |
| 01/31/2012 | CA2393251C Eliciting hcv-specific antibodies |
| 01/31/2012 | CA2391952C Inhibitors of histone deacetylase |
| 01/31/2012 | CA2380216C Use of interleukin-18 inhibitors to inhibit tumor metastasis |
| 01/31/2012 | CA2226087C Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 01/30/2012 | CA2746176A1 Animal ectoparasite-controlling agent |
| 01/30/2012 | CA2746165A1 Animal ectoparasite-controlling agent |
| 01/30/2012 | CA2746148A1 Animal ectoparasite-controlling agent |
| 01/30/2012 | CA2746107A1 Animal ectoparasite-controlling agent |
| 01/29/2012 | CA2746890A1 Novel compounds for medical use as peptidase effectors |
| 01/26/2012 | WO2012012809A2 APPLICATION OF β-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT |
| 01/26/2012 | WO2012012798A2 Materials and methods for reduction of protein tau and treatment of neurodegenerative diseases |
| 01/26/2012 | WO2012012782A1 Antifungal and antiparasitic polyene macrolides |
| 01/26/2012 | WO2012012764A1 Noribogaine compositions |
| 01/26/2012 | WO2012012736A2 Method of treating a viral infection dysfunction by disrupting an adenosine receptor pathway |
| 01/26/2012 | WO2012012716A2 Targeting micrornas for the treatment of fibrosis |
| 01/26/2012 | WO2012012712A2 Tricyclic proteasome activity enhancing compounds |
| 01/26/2012 | WO2012012710A2 Radiation sensitization agents for prostate cancer |
| 01/26/2012 | WO2012012676A2 Use of mir-29 for cell protection |
| 01/26/2012 | WO2012012656A2 Materials and methods for treating neurodegenerative diseases |
| 01/26/2012 | WO2012012642A1 Tricyclic compounds and methds of making and using same |
| 01/26/2012 | WO2012012627A1 Method of preventing or treating viral infection |
| 01/26/2012 | WO2012012619A1 Protein kinase c inhibitors and uses thereof |
| 01/26/2012 | WO2012012543A1 Methods of use cyclic amide derivatives to treat sigma receptor-mediated disorders |
| 01/26/2012 | WO2012012542A1 Methods of use of cyclic amide derivatives to treat schizophrenia |
| 01/26/2012 | WO2012012541A2 SUSTAINED RELEASE siRNA FOR OCULAR DRUG DELIVERY |
| 01/26/2012 | WO2012012513A1 Anti-viral properties of aloe vera and acquired immune deficiency syndrome (aids) treatment |
| 01/26/2012 | WO2012012498A2 Use of trp channel agonists to treat infections |
| 01/26/2012 | WO2012012478A1 Aldosterone synthase inhibitors |
| 01/26/2012 | WO2012012477A1 Substituted 3-phenyl-1,2,4-oxadiazole compounds |
| 01/26/2012 | WO2012012473A1 Use of delta tocopherol for the treatment of lysosomal storage disorders |
| 01/26/2012 | WO2012012454A1 Methods of treating metastatic breast cancer with 4-iodo-3-nitrobenzamide and irinotecan |
| 01/26/2012 | WO2012012448A1 Methods of treating breast cancer using 4-iodo-3-nitrobenzamide in combination with anti-tumor agents |
| 01/26/2012 | WO2012012410A2 Kappa opioid receptor agonists |
| 01/26/2012 | WO2012012404A1 Drug combinations with fluoro-substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions |
| 01/26/2012 | WO2012012385A2 Compositions comprising derivatives of essential oil compounds and use in personal care products |
| 01/26/2012 | WO2012012375A1 Composition for retarding and ameliorating photo induced retinal damage and cataracts while ameliorating dry eye syndrome using omega choline |